• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

富含生长因子的血浆治疗角膜上皮病变:病例系列及启示

Treatment of Corneal Epithelium Lesions with Plasma Rich in Growth Factors: A Case Series and Implications.

作者信息

Ortiz Freddy, Cárcamo Sofía, Souza-Mello Vanessa, Echeverría Sergio, Sandoval Cristian, Caamaño José

机构信息

Departamento de Especialidades Médicas, Facultad de Medicina, Universidad de la Frontera, Temuco 4811230, Chile.

Hospital Dr. Hernán Henríquez Aravena, Temuco 4811230, Chile.

出版信息

Healthcare (Basel). 2025 Sep 1;13(17):2184. doi: 10.3390/healthcare13172184.

DOI:10.3390/healthcare13172184
PMID:40941535
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12427971/
Abstract

The human eye is a remarkable organ that develops from many tissues originating from neuroectodermal, ectodermal, and mesodermal sources. If any of these essential ocular tissues are impaired, it can lead to complete vision loss. Thus, the objective of these case studies is to evaluate the impact of growth factor-rich plasma (PRGF) on the healing process of corneal epithelial injuries. This case series includes three patients with corneal epithelium lesions. The patients were treated with hyaluronic acid and matrix-regenerating agent eye drops for seven days. For a minimum of six more weeks, additional cycles of PRGF eye drops were administered. All three patients demonstrated improvements in visual acuity, reductions in ocular symptoms, and enhanced ocular surface health. In Patient 1, a good postoperative response was obtained after a second surgery. In Patient 2, after 30 days, the corneal leucoma showed a good response and complete recovery. In Patient 3, the ulcer and visual acuity improved 72 h after the treatment began. PRGF eye drops demonstrated efficacy and safety in the treatment of noninfectious corneal ulcers. Additionally, when used in conjunction with other therapies, they have the potential to augment the healing process of corneal ulcers.

摘要

人眼是一个非凡的器官,它由许多源自神经外胚层、外胚层和中胚层的组织发育而成。如果这些眼部必需组织中的任何一个受损,都可能导致完全失明。因此,这些病例研究的目的是评估富含生长因子的血浆(PRGF)对角膜上皮损伤愈合过程的影响。该病例系列包括三名角膜上皮病变患者。患者使用透明质酸和基质再生剂眼药水治疗七天。至少再过六周,额外给予PRGF眼药水疗程。所有三名患者的视力均有所改善,眼部症状减轻,眼表健康状况增强。在患者1中,第二次手术后获得了良好 的术后反应。在患者2中,30天后角膜白斑显示出良好反应并完全恢复。在患者3中,治疗开始72小时后溃疡和视力得到改善。PRGF眼药水在治疗非感染性角膜溃疡方面显示出有效性和安全性。此外,当与其他疗法联合使用时,它们有可能增强角膜溃疡的愈合过程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5311/12427971/a5b0f8d683b6/healthcare-13-02184-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5311/12427971/d735c836d34e/healthcare-13-02184-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5311/12427971/6903488f2e9f/healthcare-13-02184-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5311/12427971/c36edfac310f/healthcare-13-02184-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5311/12427971/b2cb554f7959/healthcare-13-02184-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5311/12427971/a5b0f8d683b6/healthcare-13-02184-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5311/12427971/d735c836d34e/healthcare-13-02184-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5311/12427971/6903488f2e9f/healthcare-13-02184-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5311/12427971/c36edfac310f/healthcare-13-02184-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5311/12427971/b2cb554f7959/healthcare-13-02184-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5311/12427971/a5b0f8d683b6/healthcare-13-02184-g005.jpg

相似文献

1
Treatment of Corneal Epithelium Lesions with Plasma Rich in Growth Factors: A Case Series and Implications.富含生长因子的血浆治疗角膜上皮病变:病例系列及启示
Healthcare (Basel). 2025 Sep 1;13(17):2184. doi: 10.3390/healthcare13172184.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Ophthalmia Neonatorum新生儿眼炎
4
Nocardia Keratitis诺卡菌性角膜炎
5
Lubricating drops for contact lens discomfort in adults.成人接触镜不适润滑滴眼剂。
Cochrane Database Syst Rev. 2024 Sep 5;9(9):CD015751. doi: 10.1002/14651858.CD015751.pub2.
6
Dressings and topical agents containing hyaluronic acid for chronic wound healing.含透明质酸的敷料和局部用药治疗慢性伤口愈合。
Cochrane Database Syst Rev. 2023 Jul 27;7(7):CD012215. doi: 10.1002/14651858.CD012215.pub2.
7
Sexual Harassment and Prevention Training性骚扰与预防培训
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
9
Interventions for recurrent corneal erosions.复发性角膜糜烂的干预措施。
Cochrane Database Syst Rev. 2018 Jul 9;7(7):CD001861. doi: 10.1002/14651858.CD001861.pub4.
10
Dressings and topical agents for treating venous leg ulcers.用于治疗下肢静脉溃疡的敷料和外用剂。
Cochrane Database Syst Rev. 2018 Jun 15;6(6):CD012583. doi: 10.1002/14651858.CD012583.pub2.

本文引用的文献

1
Efficacy and safety of platelet-rich plasma and autologous-serum eye drops for dry eye in primary Sjögren's syndrome: a randomized trial.富血小板血浆和自体血清滴眼液治疗原发性干燥综合征干眼症的疗效和安全性:一项随机试验。
Sci Rep. 2023 Nov 7;13(1):19279. doi: 10.1038/s41598-023-46671-2.
2
Ocular conditions and injuries, detection and management in spaceflight.航天飞行中的眼部疾病与损伤、检测与管理
NPJ Microgravity. 2023 May 16;9(1):37. doi: 10.1038/s41526-023-00279-y.
3
Autologous Platelet and Extracellular Vesicle-Rich Plasma as Therapeutic Fluid: A Review.
富自体血小板和细胞外囊泡的富含血浆作为治疗液:综述。
Int J Mol Sci. 2023 Feb 8;24(4):3420. doi: 10.3390/ijms24043420.
4
Treatment of Non-Infectious Corneal Injury: Review of Diagnostic Agents, Therapeutic Medications, and Future Targets.非感染性角膜损伤的治疗:诊断试剂、治疗药物及未来靶点的综述。
Drugs. 2022 Feb;82(2):145-167. doi: 10.1007/s40265-021-01660-5. Epub 2022 Jan 13.
5
Use of Plasma Rich in Growth Factors and ReGeneraTing Agent Matrix for the Treatment of Corneal Diseases.使用富含生长因子和再生剂基质的血浆治疗角膜疾病。
Vision (Basel). 2021 Jul 2;5(3):34. doi: 10.3390/vision5030034.
6
Corneal Ulcer in Dogs and Cats: Novel Clinical Application of Regenerative Therapy Using Subconjunctival Injection of Autologous Platelet-Rich Plasma.犬猫角膜溃疡:结膜下注射自体富血小板血浆再生疗法的新临床应用
Front Vet Sci. 2021 Mar 18;8:641265. doi: 10.3389/fvets.2021.641265. eCollection 2021.
7
Corneal stromal wound healing: Major regulators and therapeutic targets.角膜基质伤口愈合:主要调控因子和治疗靶点。
Ocul Surf. 2021 Jan;19:290-306. doi: 10.1016/j.jtos.2020.10.006. Epub 2020 Oct 28.
8
Human Platelets and Derived Products in Treating Ocular Surface Diseases - A Systematic Review.人血小板及其衍生产品治疗眼表疾病的系统评价
Clin Ophthalmol. 2020 Oct 12;14:3195-3210. doi: 10.2147/OPTH.S265701. eCollection 2020.
9
Gene therapies in ophthalmic disease.眼科疾病的基因疗法。
Nat Rev Drug Discov. 2019 Jun;18(6):415-416. doi: 10.1038/d41573-018-00016-1.
10
Current management strategy of polypoidal choroidal vasculopathy.目前息肉样脉络膜血管病变的治疗策略。
Indian J Ophthalmol. 2018 Dec;66(12):1727-1735. doi: 10.4103/ijo.IJO_975_18.